Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 112
A comprehensive review of key factors affecting the efficacy of antibody drug conjugate
Anupama Samantasinghar, Naina Sunildutt, Faheem Ahmed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114408-114408
Open Access | Times Cited: 68
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 43
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3
Tandem CAR-T cell therapy: recent advances and current challenges
Sara Gómez-Melero, Fakhri Hassouneh, Isabel M. Vallejo-Bermúdez, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 2
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Camille Moeckel, Katrina Bakhl, Ilias Georgakopoulos-Soares, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6710-6710
Open Access | Times Cited: 25
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, et al.
Cells (2024) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy
Bohan Zhang, Jiawen Wu, Hua Jiang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 320-320
Open Access | Times Cited: 1
CAR-T State of the Art and Future Challenges, A Regulatory Perspective
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19
Highly proliferative and hypodifferentiated CAR-T cells targeting B7–H3 enhance antitumor activity against ovarian and triple-negative breast cancers
Xiaoshuai Zhang, Haiyan Guo, Jie Chen, et al.
Cancer Letters (2023) Vol. 572, pp. 216355-216355
Open Access | Times Cited: 17
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7
CAR-T cell combination therapies in hematologic malignancies
Delian Zhou, Xiaojian Zhu, Yi Xiao
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
Paraskevi Vryza, Timo Fischer, Elena Mistakidi, et al.
Translational Oncology (2023) Vol. 38, pp. 101788-101788
Open Access | Times Cited: 15
Emerging Immunotherapy Approaches for Treating Prostate Cancer
Lingbin Meng, Yuanquan Yang, Amir Mortazavi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14347-14347
Open Access | Times Cited: 13
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
Yuncang Yuan, Jiawei Fan, Dandan Liang, et al.
Translational Oncology (2023) Vol. 39, pp. 101803-101803
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top